Pharmacogenetic Information in Clinical Guidelines: The European Perspective
- PMID: 29460273
- DOI: 10.1002/cpt.1049
Pharmacogenetic Information in Clinical Guidelines: The European Perspective
Abstract
Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx).1-3 In addition, patients are willing to consent to participate in PGx implementation studies.4 However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test.1,2 Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients.5,6.
© 2018 American Society for Clinical Pharmacology and Therapeutics.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
